Literature DB >> 22914548

Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons.

Erica S Levitt1, John T Williams.   

Abstract

μ-Opioid receptor desensitization is considered an initial step in the development of tolerance. Curiously, the commonly used opioid morphine produces robust tolerance but minimal acute desensitization. This study was designed to test the hypothesis that desensitization is indeed present in morphine-treated animals and is distinguished from cellular tolerance by time course of recovery and mechanism. To induce tolerance, rats were treated with continuously released morphine for 1 week. Morphine-mediated activation of G protein-coupled inwardly rectifying potassium conductance was measured using voltage-clamp recordings from locus ceruleus neurons in brain slices from naive or morphine-treated rats. Cellular tolerance was observed as a decrease in morphine efficacy in slices from morphine-treated rats. This tolerance persisted for at least 6 h. An additional reduction in morphine-mediated current was observed when slices from morphine-treated rats were continuously maintained in morphine at approximately the circulating plasma concentration. This additional reduction recovered within 1 h after removal of morphine from the slice and represents desensitization that developed in the tolerant animal. Recovery from desensitization, but not long-lasting tolerance, was facilitated by protein phosphatase 1 (PP1) activity. Furthermore, desensitization, but not tolerance, was reversed by protein kinase C (PKC) inhibitor but not by an inhibitor of c-Jun N-terminal kinase. Therefore, morphine treatment leads to both long-lasting cellular tolerance and readily reversible desensitization, which are differentially dependent on PP1 and PKC activity and combine to result in a substantial decrease in morphine effectiveness. This PKC-mediated desensitization may contribute to the previously reported PKC-dependent reversal of behavioral tolerance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914548      PMCID: PMC3477235          DOI: 10.1124/mol.112.081547

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  45 in total

1.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.

Authors:  Erica J Melief; Mayumi Miyatake; Michael R Bruchas; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

2.  A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance.

Authors:  Johan Enquist; Joseph A Kim; Selena Bartlett; Madeline Ferwerda; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-05-11       Impact factor: 4.030

Review 3.  Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.

Authors:  Vu C Dang; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization.

Authors:  Vu C Dang; Billy Chieng; Yael Azriel; MacDonald J Christie
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

5.  Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.

Authors:  Christian Doll; Jens Konietzko; Florian Pöll; Thomas Koch; Volker Höllt; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.

Authors:  Elaine K Lau; Michelle Trester-Zedlitz; Jonathan C Trinidad; Sarah J Kotowski; Andrew N Krutchinsky; Alma L Burlingame; Mark von Zastrow
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

7.  Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.

Authors:  Leon W Fyfe; Daniel R Cleary; Tara A Macey; Michael M Morgan; Susan L Ingram
Journal:  J Pharmacol Exp Ther       Date:  2010-08-25       Impact factor: 4.030

8.  Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.

Authors:  Nidia Quillinan; Elaine K Lau; Michael Virk; Mark von Zastrow; John T Williams
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

9.  Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling.

Authors:  Nitish Mittal; Miao Tan; Onyemachi Egbuta; Nina Desai; Cynthia Crawford; Cui-Wei Xie; Christopher Evans; Wendy Walwyn
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

10.  Multiple inhibitory G-protein-coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons.

Authors:  Reagan L Pennock; Matthew S Dicken; Shane T Hentges
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

View more
  29 in total

1.  Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.

Authors:  Aya Matsui; Brooke C Jarvie; Brooks G Robinson; Shane T Hentges; John T Williams
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

2.  Tolerance to the antinociceptive and hypothermic effects of morphine is mediated by multiple isoforms of c-Jun N-terminal kinase.

Authors:  Matthew B Yuill; Michael L Zee; David Marcus; Daniel J Morgan
Journal:  Neuroreport       Date:  2016-04-13       Impact factor: 1.837

3.  μ opioid receptor activation hyperpolarizes respiratory-controlling Kölliker-Fuse neurons and suppresses post-inspiratory drive.

Authors:  Erica S Levitt; Ana P Abdala; Julian F R Paton; John M Bissonnette; John T Williams
Journal:  J Physiol       Date:  2015-08-19       Impact factor: 5.182

4.  Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.

Authors:  Emily R Leff; Seksiri Arttamangkul; John T Williams
Journal:  Mol Pharmacol       Date:  2020-05-03       Impact factor: 4.436

5.  Multi-Level Regulation of Opioid-Induced Respiratory Depression.

Authors:  Barbara Palkovic; Vitaliy Marchenko; Edward J Zuperku; Eckehard A E Stuth; Astrid G Stucke
Journal:  Physiology (Bethesda)       Date:  2020-11-01

6.  Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition.

Authors:  Rob Hill; William L Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Br J Pharmacol       Date:  2018-05-07       Impact factor: 8.739

Review 7.  A cellular perspective of bias at G protein-coupled receptors.

Authors:  Thomas J Fernandez; Monica De Maria; Braden T Lobingier
Journal:  Protein Sci       Date:  2020-04-27       Impact factor: 6.725

Review 8.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

9.  Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons.

Authors:  Javier Llorente; Sarah Withey; Guadalupe Rivero; Margaret Cunningham; Alex Cooke; Kunal Saxena; Jamie McPherson; Sue Oldfield; William L Dewey; Chris P Bailey; Eamonn Kelly; Graeme Henderson
Journal:  Mol Pharmacol       Date:  2013-05-28       Impact factor: 4.436

10.  Desensitization of functional µ-opioid receptors increases agonist off-rate.

Authors:  John T Williams
Journal:  Mol Pharmacol       Date:  2014-04-18       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.